Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMBI
2526
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $1.19M | ﹤0.01% |
213,081
+10,923
| +5% | +$51.9K |
|
|
COWN
2527
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.19M | ﹤0.01% |
77,378
+8,328
| +12% | +$135K |
|
|
CSS
2528
DELISTED
CSS Industries, Inc.
CSS
| $1.19M | ﹤0.01% |
299,119
+27,100
| +10% | +$123K |
|
|
CTHR
2529
DELISTED
Charles & Colvard Ltd
CTHR
| $1.19M | ﹤0.01% |
72,804
+13,297
| +22% | +$193K |
|
2530
Hennessy Advisors
HNNA
$78.7M
| $1.18M | ﹤0.01% |
109,524
+21,804
| +25% | +$216K |
|
2531
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $1.18M | ﹤0.01% |
+24,100
| New | +$1.2M |
|
2532
Hartford Financial Services
HIG
$37.9B
| $1.17M | ﹤0.01% |
19,300
-261,722
| -93% | -$15.3M |
|
|
ONIT
2533
Onity Group
ONIT
$328M
| $1.17M | ﹤0.01% |
41,502
+20,340
| +96% | +$568K |
|
2534
uniQure
QURE
$3.28B
| $1.17M | ﹤0.01% |
29,700
-144,000
| -83% | -$8.31M |
|
|
SOL
2535
DELISTED
Emeren Group
SOL
| $1.16M | ﹤0.01% |
778,851
+14,141
| +2% | +$16.4K |
|
|
BCLI
2536
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.16M | ﹤0.01% |
19,809
+4,851
| +32% | +$286K |
|
2537
International Seaways
INSW
$4.79B
| $1.16M | ﹤0.01% |
60,200
-55,400
| -48% | -$979K |
|
2538
Amalgamated Financial
AMAL
$1.52B
| $1.16M | ﹤0.01% |
72,300
+56,500
| +358% | +$922K |
|
|
NNA
2539
DELISTED
Navios Maritime Acquisition Corporation
NNA
| $1.16M | ﹤0.01% |
171,856
+87,076
| +103% | +$559K |
|
|
INFI
2540
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.16M | ﹤0.01% |
1,120,940
+118,934
| +12% | +$162K |
|
|
VOLT
2541
DELISTED
Volt Information Sciences, Inc.
VOLT
| $1.15M | ﹤0.01% |
363,810
+45,603
| +14% | +$175K |
|
2542
AudioCodes
AUDC
$254M
| $1.15M | ﹤0.01% |
+60,700
| New | +$1.09M |
|
2543
MIND Technology
MIND
$42.9M
| $1.15M | ﹤0.01% |
35,335
+1,353
| +4% | +$50.7K |
|
2544
ProShares Short 20+ Year Treasury ETF
TBF
$107M
| $1.15M | ﹤0.01% |
61,100
+6,000
| +11% | +$117K |
|
2545
The GEO Group
GEO
$4.04B
| $1.15M | ﹤0.01% |
66,100
-338,600
| -84% | -$6.07M |
|
2546
Zumiez
ZUMZ
$316M
| $1.14M | ﹤0.01% |
35,900
+25,800
| +255% | +$680K |
|
2547
iShares Russell 1000 Value ETF
IWD
$84.3B
| $1.13M | ﹤0.01% |
+8,800
| New | +$1.12M |
|
|
BSCJ
2548
DELISTED
Invesco BulletShares 2019 Corporate Bond ETF
BSCJ
| $1.13M | ﹤0.01% |
53,463
-56,931
| -52% | -$1.2M |
|
2549
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
| $1.12M | ﹤0.01% |
33,400
+5,578
| +20% | +$184K |
|
2550
MaxLinear
MXL
$7.53B
| $1.12M | ﹤0.01% |
+50,213
| New | +$1.11M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.